A Cost-effectiveness Analysis of an Internet-delivered Pain Management Program Delivered With Different Levels of Clinician Support: Results From a Randomised Controlled Trial.


Journal

The journal of pain
ISSN: 1528-8447
Titre abrégé: J Pain
Pays: United States
ID NLM: 100898657

Informations de publication

Date de publication:
03 2021
Historique:
received: 10 08 2020
revised: 27 10 2020
accepted: 02 11 2020
pubmed: 24 11 2020
medline: 15 12 2021
entrez: 23 11 2020
Statut: ppublish

Résumé

There is growing interest in the potential of internet-delivered pain management programs (PMPs) to increase access to care for people with chronic pain. However, very few economic evaluations of these interventions have been reported. Using existing data, the current study examined the cost-effectiveness of an internet-delivered PMP for a mixed group chronic pain patients (n = 490) provided with different levels of clinician support. The findings indicated that each additional clinical outcome (defined as a ≥ 30% reduction in disability, depression, anxiety, and pain) was associated with cost-savings when the intervention was provided in a self-guided format (ICER range: -$404--$808 AUD) or an optional-guided format (ICER range: -$314--$541 AUD), and a relatively small fixed cost when provided in the clinician-guided format (ICER range: $88-$225 AUD). The results were driven by a reduction in service use costs among the treatment groups, which offset the costs of providing the internet-delivered PMP in the self-guided and optional-guided formats. The same general pattern of results was found when more stringent clinical outcomes (defined as a ≥ 50% reduction) were employed. These findings suggest that carefully developed and administered internet-delivered PMPs, provided with different levels of clinician support, can be highly cost effective for patients with a broad range of pain conditions. PERSPECTIVE: This study examines the cost-effectiveness of an internet-delivered PMP provided to adults with a broad range of chronic pain conditions. Evidence of cost-effectiveness was found across a broad range of clinical outcomes and with different levels of clinician support.

Identifiants

pubmed: 33227510
pii: S1526-5900(20)30104-8
doi: 10.1016/j.jpain.2020.11.003
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

344-358

Informations de copyright

Copyright © 2020 United States Association for the Study of Pain, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Blake F Dear (BF)

eCentreClinic, Department of Psychology, Macquarie University, Sydney, Australia. Electronic address: blake.dear@mq.edu.au.

Eyal Karin (E)

eCentreClinic, Department of Psychology, Macquarie University, Sydney, Australia.

Rhiannon Fogliati (R)

eCentreClinic, Department of Psychology, Macquarie University, Sydney, Australia.

Joanne Dudeney (J)

eCentreClinic, Department of Psychology, Macquarie University, Sydney, Australia.

Olav Nielssen (O)

eCentreClinic, Department of Psychology, Macquarie University, Sydney, Australia.

Amelia J Scott (AJ)

eCentreClinic, Department of Psychology, Macquarie University, Sydney, Australia.

Milena Gandy (M)

eCentreClinic, Department of Psychology, Macquarie University, Sydney, Australia.

Madelyne A Bisby (MA)

eCentreClinic, Department of Psychology, Macquarie University, Sydney, Australia.

Andreea I Heriseanu (AI)

eCentreClinic, Department of Psychology, Macquarie University, Sydney, Australia.

Taylor Hathway (T)

eCentreClinic, Department of Psychology, Macquarie University, Sydney, Australia.

Lauren Staples (L)

eCentreClinic, Department of Psychology, Macquarie University, Sydney, Australia.

Nickolai Titov (N)

eCentreClinic, Department of Psychology, Macquarie University, Sydney, Australia.

Liz Schroeder (L)

Centre for Health Economy, Macquarie University, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH